Medtronic Statistics

Total Valuation

Medtronic has a market cap or net worth of GBP 91.30 billion. The enterprise value is 106.26 billion.

Market Cap	91.30B
Enterprise Value	106.26B

Important Dates

The last earnings date was Tuesday, February 18, 2025.

Earnings Date	Feb 18, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.53%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.28B

Valuation Ratios

The trailing PE ratio is 26.77.

PE Ratio	26.77
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.75, with an EV/FCF ratio of 24.28.

EV / Earnings	31.15
EV / Sales	4.05
EV / EBITDA	13.75
EV / EBIT	19.69
EV / FCF	24.28

Financial Position

The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.54.

Current Ratio	1.90
Quick Ratio	1.19
Debt / Equity	0.54
Debt / EBITDA	2.72
Debt / FCF	4.87
Interest Coverage	9.01

Financial Efficiency

Return on equity (ROE) is 8.44% and return on invested capital (ROIC) is 5.56%.

Return on Equity (ROE)	8.44%
Return on Assets (ROA)	4.72%
Return on Invested Capital (ROIC)	5.56%
Return on Capital Employed (ROCE)	8.73%
Revenue Per Employee	279,805
Profits Per Employee	35,904
Employee Count	95,000
Asset Turnover	0.37
Inventory Turnover	2.02

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.24% in the last 52 weeks. The beta is 0.86, so Medtronic's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	+4.24%
50-Day Moving Average	85.90
200-Day Moving Average	85.17
Relative Strength Index (RSI)	53.09
Average Volume (20 Days)	6,592

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.04

Income Statement

In the last 12 months, Medtronic had revenue of GBP 26.58 billion and earned 3.41 billion in profits. Earnings per share was 2.62.

Revenue	26.58B
Gross Profit	17.43B
Operating Income	5.46B
Pretax Income	4.18B
Net Income	3.41B
EBITDA	7.60B
EBIT	5.46B
Earnings Per Share (EPS)	2.62

Full Income Statement

Balance Sheet

The company has 6.34 billion in cash and 21.30 billion in debt, giving a net cash position of -14.96 billion.

Cash & Cash Equivalents	6.34B
Total Debt	21.30B
Net Cash	-14.96B
Net Cash Per Share	n/a
Equity (Book Value)	39.73B
Book Value Per Share	30.81
Working Capital	8.55B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.84 billion and capital expenditures -1.46 billion, giving a free cash flow of 4.38 billion.

Operating Cash Flow	5.84B
Capital Expenditures	-1.46B
Free Cash Flow	4.38B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 65.57%, with operating and profit margins of 20.55% and 12.83%.

Gross Margin	65.57%
Operating Margin	20.55%
Pretax Margin	15.73%
Profit Margin	12.83%
EBITDA Margin	28.61%
EBIT Margin	20.55%
FCF Margin	16.47%

Dividends & Yields

This stock pays an annual dividend of 2.18, which amounts to a dividend yield of 2.43%.

Dividend Per Share	2.18
Dividend Yield	2.43%
Dividend Growth (YoY)	-0.85%
Years of Dividend Growth	n/a
Payout Ratio	84.62%
Buyback Yield	2.53%
Shareholder Yield	4.95%
Earnings Yield	3.74%
FCF Yield	4.79%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medtronic has an Altman Z-Score of 2.88. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.88
Piotroski F-Score	n/a